| Terminated | A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir) Non-small Cell Lung Cancer | Phase 1 | 2023-04-05 |
| Terminated | A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Metastatic Cancer, Soft Tissue Sarcoma, Merkel Cell Carcinoma | Phase 1 / Phase 2 | 2021-02-25 |
| Terminated | Study of Intrahepatic Arterial Infusion of TG6002 in Combination With 5-FC in Patients With Metastatic Colorec Colorectal Neoplasms | Phase 1 / Phase 2 | 2020-01-17 |
| Active Not Recruiting | A Clinical Trial Evaluating TG4050 in Head and Neck Cancer Squamous Cell Carcinoma of Head and Neck | Phase 1 / Phase 2 | 2019-12-12 |
| Completed | A Trial Evaluating TG4050 in Ovarian Carcinoma. Ovarian Carcinoma, Fallopian Tube Cancer, Peritoneal Carcinoma | Phase 1 | 2019-12-09 |
| Terminated | Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors. Colorectal Neoplasm, Digestive System Neoplasm | Phase 1 / Phase 2 | 2018-10-16 |
| Completed | A Study Evaluating the Efficacy and the Safety of First-line Chemotherapy Combined With the Therapeutic Vaccin Non Small Cell Lung Cancer Metastatic | Phase 2 | 2018-01-05 |
| Active Not Recruiting | Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, HPV-Related Anal Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2017-09-01 |
| Terminated | A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With th Hepatocellular Carcinoma (HCC) | Phase 1 / Phase 2 | 2017-07-27 |
| Completed | Safety and Tolerability of TG1050: A Dose-finding Study Chronic Hepatitis B | Phase 1 | 2015-10-01 |
| Completed | Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients Wi Chronic Hepatitis B | N/A | 2014-12-01 |
| Terminated | Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer Non-Small-Cell Lung Carcinoma | Phase 2 / Phase 3 | 2012-04-01 |
| Completed | Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Pat Chronic Hepatitis C Infection | Phase 2 | 2010-05-01 |
| Completed | Trial of TG4023 Combined With Flucytosine in Liver Tumors Hepatocellular Carcinoma | Phase 1 | 2009-09-01 |
| Completed | Immunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C Virus Hepatitis C, Chronic | Phase 1 | 2006-12-01 |
| Completed | Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma Lymphoma, B-Cell | Phase 2 | 2006-11-01 |
| Completed | Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer Carcinoma, Non-Small-Cell Lung | Phase 2 / Phase 3 | 2005-12-01 |
| Terminated | Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer Prostatic Neoplasms | Phase 2 | 2002-05-01 |